Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)
Teva officially shutters the doors to a troubled Southern California site
While FDA investigators earlier this year found issues at Teva Pharmaceuticals’ plant in Irvine, CA, forcing the company to padlock the doors, the company has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.